{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:42Z","timestamp":1792166562928,"version":"4.4.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>The respiratory rate-oxygenation (ROX) index is a fraction of oxygen saturation, F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>, and respiratory rate that has been validated to predict receipt of invasive mechanical ventilation in patients receiving high-flow nasal cannula (HFNC). This study aimed to validate ROX in a cohort of inpatients with COVID-19\u2013related respiratory failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective validation of the ROX index. We calculated sensitivity, specificity, positive predictive value, negative predictive value, and 95% CIs of ROX for invasive mechanical ventilation any time during hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Twenty-one hospitals of Kaiser Permanente Northern California, an integrated healthcare delivery system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>We identified adults with positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test within 3 weeks of, or during, hospitalization between February 1, 2020, and December 31, 2020. We calculated ROX at 12 hours after HFNC initiation. We grouped patients as low (\u2265 4.88), intermediate (&lt; 4.88 and \u2265 3.85), or high (&lt; 3.85) risk using previously published thresholds.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We identified 1,847 patients who had no limitation of life support. Of these, 525 (31.7%) received invasive mechanical ventilation any time during hospitalization and 511 died (27.7%). The sensitivity, specificity, positive predictive value, and negative predictive value of 12-hour ROX threshold (&lt; 3.85) predicting invasive mechanical ventilation were 32.3% (95% CI, 28.5\u201336.3%), 89.8% (95% CI, 88.0\u201391.4%), 59.4% (95% CI, 53.8\u201364.9%), and 74.1% (95% CI, 71.8\u201376.3%), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>The 12-hour ROX index has a positive predictive value (59.4%) using threshold of less than 3.85 for COVID-19 patients needing invasive mechanical ventilation. Our health system has embedded ROX into the electronic health record to prioritize rounding during periods of inpatient surge.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000005474","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T22:13:27Z","timestamp":1644012807000},"page":"e638-e642","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19\u2013Related Respiratory Failure"],"prefix":"10.1097","volume":"50","author":[{"given":"Laura C.","family":"Myers","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, CA."},{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Mark","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Ley","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Guarnieri","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Hofmeister","sequence":"additional","affiliation":[{"name":"Respiratory Therapy, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Paulson","sequence":"additional","affiliation":[{"name":"Adult Patient Care Services, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Marelich","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent X.","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, CA."},{"name":"The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1164\/rccm.202005-2007LE","article-title":"High-flow nasal cannula in critically ill patients with severe COVID-19.","volume":"202","author":"Demoule","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","article-title":"An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy.","volume":"199","author":"Roca","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2016.05.022","article-title":"Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.","volume":"35","author":"Roca","year":"2016","journal-title":"J Crit Care"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MLR.0b013e3182881c8e","article-title":"Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system.","volume":"51","author":"Escobar","year":"2013","journal-title":"Med Care"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMsa2001090","article-title":"Automated identification of adults at risk for in-hospital clinical deterioration.","volume":"383","author":"Escobar","year":"2020","journal-title":"N Engl J Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-015-0999-1","article-title":"Why the C-statistic is not informative to evaluate early warning scores and what metrics to use.","volume":"19","author":"Romero-Brufau","year":"2015","journal-title":"Crit Care"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s00134-020-06177-1","article-title":"Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.","volume":"46","author":"Zucman","year":"2020","journal-title":"Intensive Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4187\/respcare.08631","article-title":"High-flow nasal cannula therapy in COVID-19: Using the ROX index to predict success.","volume":"66","author":"Chandel","year":"2021","journal-title":"Respir Care"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1513\/AnnalsATS.202008-934RL","article-title":"Ratio of oxygen saturation index to guide management of COVID-19 pneumonia.","volume":"18","author":"Fink","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bmjqs-2017-006671","article-title":"Is everyone really breathing 20 times a minute? Assessing epidemiology and variation in recorded respiratory rate in hospitalised adults.","volume":"26","author":"Badawy","year":"2017","journal-title":"BMJ Qual Saf"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:02:22Z","timestamp":1746208942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000005474","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}